Details

Postopek izdaje gradbenega dovoljenja : diplomsko delo
ID Knez, Špela (Author), ID Virant, Grega (Mentor) More about this mentor... This link opens in a new window

.pdfPDF - Presentation file, Download (818,69 KB)
MD5: C8CEEB502467DB0234EFAC1389086AE9
PID: 20.500.12556/rul/73ef8406-5371-4490-8ccc-ad68a15d1fe3

Language:Slovenian
Keywords:gradbeno dovoljenje, investitor, upravne enote, upravni postopek, diplomske naloge
Work type:Undergraduate thesis
Typology:2.11 - Undergraduate Thesis
Organization:FU - Faculty of Administration
Place of publishing:Ljubljana
Publisher:[Š. Knez]
Year:2012
Number of pages:X, 81 str.
PID:20.500.12556/RUL-2754 This link opens in a new window
UDC:351.778.511(043.2)
COBISS.SI-ID:3850670 This link opens in a new window
Publication date in RUL:11.07.2014
Views:2783
Downloads:607
Metadata:XML DC-XML DC-RDF
:
KNEZ, Špela, 2012, Postopek izdaje gradbenega dovoljenja : diplomsko delo [online]. Bachelor’s thesis. Ljubljana : Š. Knez. [Accessed 17 April 2025]. Retrieved from: https://repozitorij.uni-lj.si/IzpisGradiva.php?lang=eng&id=2754
Copy citation
Share:Bookmark and Share

Similar documents

Similar works from RUL:
  1. Systematic review of observational studies evaluating the effectiveness and safety of immune checkpoint inhibitors in patients with metastatic non-small-cell lung cancer
  2. Effectivness and safety of immunotherapy in patients with advanced non-small cell lung cancer in second line treatment at the University Clinic Golnik
  3. Description of adverse event of immune checkpoint inhibitors in patients with advanced non-small cell lung cancer treated at the University Clinic Golnik
  4. ǂThe ǂpotential of immunotherapies in the treatment of lung cancer
  5. Real-world outcomes of immunotherapy with or without chemotherapy in first-line treatment of advanced non-small cell lung cancer
Similar works from other Slovenian collections:
  1. Advances in the therapy with immune-check point inhibitors (ICI) in non-small cell lung cancer (NSCLC) in 2022
  2. Trans-esophageal endobronchial ultrasound-guided needle aspiration (EUS-B-NA)
  3. ǂThe ǂrole of immune checkpoint inhibitors in the treatment of cancer of unknown origin
  4. Febrile neutropenia and grade 3/4 neutropenia in daily practice of adjuvant chemotherapy for non-small-cell lung cancer
  5. Neurological adverse events of immune checkpoint inhibitors

Back